| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0021 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |